crisantaspase
SpainDrugs containing this active substance
-
It is primarily used in children to treat acute lymphoblastic leukemia (a type of white blood cell cancer), especially in patients who have had allergic reactions to other similar medications.
Form: powder for injectable solution and for perfusion
Active substance Dosage crisantaspase 10.000 UI Manufacturer: Porton Biopharma Limited